5,5'-((3,3',5,5'-Tetramethyl-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))bis(isobenzofuran-1,3-dione)

Catalog No. :
ACBWJB377
CAS No. :
150314-47-9
Molecular Formula :
C32H22O8
Molecular Weight :
534.52

IUPAC Name:5,5'-((3,3',5,5'-tetramethyl-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))bis(isobenzofuran-1,3-dione)

5,5'-((3,3',5,5'-Tetramethyl-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))bis(isobenzofuran-1,3-dione) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,5'-((3,3',5,5'-Tetramethyl-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))bis(isobenzofuran-1,3-dione)
IUPAC Name5,5'-((3,3',5,5'-tetramethyl-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))bis(isobenzofuran-1,3-dione)
MDL No.-
Molecular FormulaC32H22O8
Molecular Weight534.52
SMILESCC1=C(OC2=CC3=C(C(OC3=O)=O)C=C2)C(C)=CC(C4=CC(C)=C(OC5=CC6=C(C(OC6=O)=O)C=C5)C(C)=C4)=C1
InChI KeyQEAUDLXEHPHORX-UHFFFAOYSA-N
Synonym1,3-Isobenzofurandione, 5,5'-[(3,3',5,5'-tetramethyl[1,1'-biphenyl]-4,4'-diyl)bis(oxy)]bis-;5,5'-((3,3',5,5'-tetramethyl-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))bis(isobenzofuran-1,3-dione);5,5'-[(3,3',5,5'-Tetramethyl[1,1'-biphenyl]-4,4'-diyl)bis(oxy)]bis-1,3-isobenzofurandione;5,5'-((3,3',5,5'-tetramethyl-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))bis(isobenzofuran-1,3-dione) BTMDA;BTMDA
CAS No.150314-47-9

Synthetic Route by SureRoute

1. ACBWJB377 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBWJB377 route product structure diagram
    ACBWJB377150314-47-9
Inquiry

2. ACBWJB377 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBWJB377 route product structure diagram
    ACBWJB377150314-47-9
Inquiry

Comments (0)